NeurAeonTechnologies
Home About Our Mission Research & Tech Digital Shadow Meet The Team Contact Invest
Research-stage software initiative

Scientific intelligence, with the evidence attached.

Digital Shadow is NeurAeon Technologies' emerging pharmaceutical R&D decision-support platform. Its objective: bring scientific evidence, early process-risk questions, and structured development documentation into one human-governed workflow.

Public-facing conceptual diagrams only. Not a live Digital Shadow application, chemical model, proprietary architecture disclosure, or validation demonstration.

Evidence-awareExpert-ledPre-validation
NEURAEON // DIGITAL SHADOW
CONCEPTUAL SYSTEM VIEW
InputsEvidence & context
ReviewHuman authority
OutputsDraft artifacts
01 / Research pathway

One research journey. Seven connected questions.

Select a stage to see the type of work Digital Shadow is intended to support. This diagram describes the proposed product workflow, not a verified end-to-end execution.

Step 01

Molecular identity & context

Define the scientific question before assessment begins.

02 / Coordinated intelligence

Different analytical lenses. One accountable process.

Explore an illustrative model of specialist responsibilities. Node names represent intended roles; they do not certify operational autonomous agents or reveal internal implementation details.

PUBLIC CONCEPT NETWORK DIGITALSHADOW Evidencereview Chemistryassessment Riskinvestigation Documentassembly Humanreview
Public concept model

Evidence review

Explore example responsibilities.

03 / Early scientific uncertainty

Make the unknowns visible.

This interactive panel illustrates categories a scientist might investigate. It is not a predictive risk score, live scientific result, or assessment of a particular molecule.

Stability · investigation question

Which conditions could require verification?

04 / Development program

Credibility is built in stages.

These are development phases, not guaranteed completion dates or claims that scientific validation has already occurred.

PHASE 01Prototype activity

Build & integrate

Develop user workflows, scientific workspaces, research interfaces and technical document generation.

PHASE 02Validation objective

Test rigorously

Benchmark the science, document limitations, obtain qualified review and resolve critical failure modes.

PHASE 03Planned

Partner & refine

Explore bounded evaluations with suitable pharmaceutical development teams and scientific collaborators.

PHASE 04Long-term aim

Commercial readiness

Strengthen security, reliability, scientific performance, governance and enterprise operations.

05 / Transparent boundaries

Show the vision. Protect the invention.

NeurAeon can explain the purpose and value of Digital Shadow without publishing its private technical work.

Appropriate for this website

Public product story

  • High-level workflow concepts and scientific problem statements
  • Non-operational visual demonstrations
  • Development status, limitations and validation goals
  • Partnership and research opportunities
Kept private

Internal engineering details

  • Source code, prompt architectures and orchestration rules
  • Private agent configurations and evaluation datasets
  • Unreleased molecule dossiers and customer information
  • Infrastructure, credentials, endpoints and confidential IP